Why Seed valuations are negotiated, not calculated
At pre-revenue stage, there is no formula that produces an objective valuation. The number is a negotiated outcome anchored to: what comparable companies in your sector and region have raised at, how strong the founding team's credentials are, how large and urgent the problem is, and how much conviction the lead investor has. Understanding the anchors helps you negotiate — rather than accepting the first number offered.
Regional Seed benchmarks (2025–2026)
US (San Francisco / New York): Pre-money Seed valuations of $6M–$15M are common for teams with prior exits or strong domain credibility. Pure idea-stage companies without traction: $3M–$6M. Europe (London, Berlin, Paris): $3M–$10M pre-money. DACH specifically: $2M–$6M for first-time founders, $5M–$12M for repeat founders. These ranges compress and expand with market conditions. In 2021, Seed valuations were 30–50% higher. The current environment is more founder-friendly than 2022–2023 but below 2021 peaks.
What moves Seed valuation up
Prior exit (even a small one) by the founding team. Deep domain expertise directly relevant to the problem. Early customer validation: signed LOIs, paid pilots, waitlist with strong conversion. Proprietary technology or data moat. Competing term sheets — the single most powerful lever in any valuation negotiation.
SAFE vs priced round at Seed
Most Seed rounds today are done on SAFEs (Simple Agreement for Future Equity) rather than priced equity rounds. A SAFE has a valuation cap (the maximum pre-money valuation at which the SAFE converts) and often a discount (typically 15–20% off the Series A price). SAFEs defer the valuation negotiation to the Series A — which can be founder-friendly if you expect the Series A valuation to be significantly higher than the cap. The risk: multiple SAFEs at different caps create cap table complexity that can slow Series A due diligence.